IP Library › Assignment 051304/0062
Patent Assignment
Reel/Frame 051304/0062

Assignment of Assignor's Interest

Recorded: 2019-12-17 Pages: 5
Assignors
EL-KATTAN, YAHYA
Executed: 2019-12-03
BABU, YARLAGADDA S.
Executed: 2019-12-03
Assignee
BIOCRYST PHARMACEUTICALS, INC.
4505 EMPEROR BLVD., SUITE 200, DURHAM, NORTH CAROLINA, 27703
Covered Property (1)
Crystalline Salts of a Plasma Kallikrein Inhibitor
Application: 16/671,649 →
Publication: US 2020/0140389
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Apr 10, 2023
From: BIOCRYST PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
Reel/Frame 063284/0001 →
Corrective Assignment to Correct the Patent Number 10622160 Should Be Patent Number 10662160 Previously Recorded at Reel: 063284 Frame: 0001. Assignor(S) Hereby Confirms the Assignment. Apr 12, 2023
From: BIOCRYST PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
Reel/Frame 063308/0475 →
Release of Grant of Security Interest in Patents Apr 18, 2023
From: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 063362/0550 →
Patent Security Agreement Apr 19, 2023
From: BIOCRYST PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 063363/0873 →
Termination and Release of Security Interest in Patent Collateral Recorded at Reel 063363/Frame 0873 Oct 8, 2025
From: BIOPHARMA CREDIT PLC
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 073056/0492 →
Security Interest Jan 23, 2026
From: BIOCRYST PHARMACEUTICALS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 074485/0651 →